- BioNTech oncology acquisition to advance bispecific antibodies November 14, 2024
- Gilead data lends insight into transforming HIV prevention landscape November 13, 2024
- New $3.5b AstraZeneca investment to accelerate US R&D and manufacturing November 12, 2024
- Major immunotherapy trial sees survival benefit in solid tumours November 11, 2024
- Innovative static culturing method developed November 8, 2024
- Single-use bioreactor market to witness favourable expansion to 2030 November 7, 2024
- Celltrion Launches STEQEYMA (ustekinumab) in Germany and the Netherlands November 14, 2024
- FDA Accepts BLA for Shanghai Henlius Biotech’s and Organon’s HLX14, a Denosumab Biosimilar November 7, 2024
- Daewoong and Celltrion to Market Denosumab Biosimilar in Korea November 7, 2024
- EMA Accepts Marketing Authorization Application for Alvotech’s AVT05 (golimumab) November 6, 2024
- Alvotech Requests that FDA Refuse to License CHO-Cell Derived Ustekinumab Biosimilars as Interchangeable Until the Effects of Sialylation Are Evaluated November 5, 2024
- Trump nominates RFK Jr. to lead HHS November 14, 2024
- No link between telehealth and low-value services in primary care: study November 14, 2024
- CMS to lower importance of ‘call center’ metric in Medicare Advantage star ratings November 14, 2024
- Cardinal Health inks 2 acquisitions worth $3.9B November 14, 2024
- Health systems band together to test and publicly rank top AI models November 14, 2024
- Tenet CEO looks ahead to second Trump term November 13, 2024
- Centene President Ken Fasola to retire next year November 13, 2024
- J&J sues federal government for halting 340B rebate plan November 13, 2024
- Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market November 13, 2024
- Drug Channels Outlook 2025 (NEW Live Video Webinar) November 12, 2024
- How the Perfect Storm Will Impact Patient Support Programming in 2025 and Beyond November 8, 2024
- Transparency Shocker: Biosimilars Are Getting Cheaper—But Hospitals and Insurers Can Make Them Expensive November 4, 2024
- How Field Reimbursement Services Help Overcome Coverage Barriers and Improve Patient Outcomes November 1, 2024
- Drug Channels News Roundup, October 2024: Humira Price War Update, PA vs. Providers, IRA vs. Physicians, My AI Podcast, New DCI Jobs, and Dr. G on Copayments October 29, 2024
- No More Delays: Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows October 25, 2024